![](https://www.quarkbiosciences.com/wp-content/uploads/2021/04/NextAmp-Analysis-System-iF-Design-1200x630-1-740x630.jpg)
![quarkbio-slider-06 2022 Healthcare EXPO](http://www.quarkbiosciences.com/wp-content/plugins/revslider/public/assets/assets/transparent.png)
![](http://www.quarkbiosciences.com/wp-content/uploads/2021/06/nextamp-analysis-system-quarkbio.png)
2023 BIO ASIA-Taiwan
A Chip-based Clinically Oriented qPCR
NextAmp™ Analysis System
Virtual Exhibition
JUL 27 - JUL 30
![Oncogenic Druggable Fusion Slide BG ps](http://www.quarkbiosciences.com/wp-content/uploads/2022/05/Oncogenic-Druggable-Fusion-Slide-BG-ps.jpg)
Oncogenic Druggable Fusion
First line screening for possible fusion-targeted therapy
![](http://www.quarkbiosciences.com/wp-content/uploads/2022/05/Oncogenic-Druggable-Fusion-Slide-BG-ps.jpg)
![quarkbio-slider-06 ThyroSCAN](http://www.quarkbiosciences.com/wp-content/plugins/revslider/public/assets/assets/transparent.png)
Indeterminate
Thyroid Nodule Cytology
![](http://www.quarkbiosciences.com/wp-content/uploads/2022/06/Home-Slider-Thyroid-Banner.jpg)
Solution: Risk stratification through fast, affordable molecular analysis
![quarkbio-slider-06 Customized Services](http://www.quarkbiosciences.com/wp-content/plugins/revslider/public/assets/assets/transparent.png)
Insight to Action
![](http://www.quarkbiosciences.com/wp-content/uploads/2022/06/Home-Slider-PanelChip-Banner.jpg)
Transform your research into clinical-actionable product
![quarkbio-slider-06](http://www.quarkbiosciences.com/wp-content/uploads/2021/06/quarkbio-slider-06.jpg)
![](http://www.quarkbiosciences.com/wp-content/uploads/2021/06/iF-DESIGN-AWARD-2021-logo-1.jpg)
NextAmp™
Analysis System
![](http://www.quarkbiosciences.com/wp-content/uploads/2021/06/nextamp-analysis-system-quarkbio.png)
A dual-functioning system capable of multi-biomarker analysis and digital detection of low quantity genes
![quarkbio-slider-01c](http://www.quarkbiosciences.com/wp-content/uploads/2020/08/quarkbio-slider-01c.jpg)
Innovation through Collaborations
We collaborate for your success by customizing smarter and more suitable biomarker solution to meet your clinical needs
![DigiChip Digital qPCR-01](http://www.quarkbiosciences.com/wp-content/uploads/2020/07/DigiChip-Digital-qPCR-01.jpg)
High Tolerance for Sample Quality
Our assays enable more patients to receive suitable drug treatments with the ability to analyze poor quality and low concentration samples
![quarkbio-slider-03c](http://www.quarkbiosciences.com/wp-content/uploads/2020/08/quarkbio-slider-03c.jpg)
Pinpoint Eligible Patients
PanelChip® offers a cost-effective platform for large scale screening of patient with rare gene rearrangements
![quarkbio-slider-04](http://www.quarkbiosciences.com/wp-content/uploads/2020/07/quarkbio-slider-04.jpg)
Proven Clinical Utility with Expression Biomarkers
Translating discoveries into products, we have helped multiple companies develop mRNA- and miRNA-based assay
What We Do
Simple to use cancer panels for actionable mutations and diagnosis
Why QuarkBio?
Latest News
![](https://www.quarkbiosciences.com/wp-content/uploads/2021/04/NextAmp-Analysis-System-iF-Design-1200x630-1-740x630.jpg)
Events
BIO Asia-Taiwan 2023 Exhibition
CONFERENCE
Exhibition: Jul 27 – Jul 30,2023
Location: Taipei Nangang Exhibition Center,Hall 1,4F (M514)
Healthcare Expo | Taiwan
CONFERENCE
Exhibition: Dec 01 – 04, 2022
Location: Taipei Nangang Exhibition Center, Hall 1, 1、4F (L003)